Trial lecture and disputation October 27-28th
Kristine Gulliksrud
Siv. ing. Kristine Gulliksrud from Einar Rofstad's group at the Department of Radiation Biology at the Institute for Cancer Research will give her trial lectures on Thursday October 27th. The lecture over the subject of her own choice - "Assessment of tumor pH by magnetic resonance spectroscopy and imaging" starts at 14:15. The given subject is "Therapeutic approaches for dealing with the hypoxia problem", and this lecture begins at 15:15. Both trial lectures take place in the Auditorium in the Research Therapy Building at the OUS-Radiumhospitalet, Montebello. She will defend her PhD thesis - entitled "DCE-MRI in assessment of the microenvironment and aggressiveness of human tumor xenografts" the following day, on Friday October 28th at 10:15. The disputation takes place in the "Lille Fysiske auditorium, Fysikkbygningen" at the University of Oslo.
Yao Y, Sun H, Wurihan, Gegeheng, Gezi, Skarstad K, Fan L, Morigen(2023) A DnaA‐dependent riboswitch for transcription attenuation of the his operon mLife, 2(2), 126-140 DOI 10.1002/mlf2.12075, PublikaID 479
Silwal-Pandit L, Stålberg SM, Henrik J. Johansson, Georgios Mermelekas, Lothe IMB, Skrede ML, Dalsgaard AM, Nebdal D, Helland, Lingjærde OC, Labori KJ, Skålhegg BS, Janne Lehtiö, Kure EH(2022) Proteome Analysis of Pancreatic Tumors Implicates Extracellular Matrix in Patient Outcome Cancer Res Commun, 2(6), 434-446 DOI 10.1158/2767-9764.CRC-21-0100, PublikaID 411
Tryggestad AMA, Axcrona K, Axcrona U, Bigalke I, Brennhovd B, Inderberg EM, Honnashagen TK, Skoge LJ, Solum G, Saeboe-Larssen S, Josefsen D, Olaussen RW, Aamdal S, Skotheim RI, Myklebust TA, Schendel DJ, Lilleby W, Dueland S, Kvalheim G(2022) Long-term first-in-man Phase I/II study of an adjuvant dendritic cell vaccine in patients with high-risk prostate cancer after radical prostatectomy Prostate, 82(2), 245-253 DOI 10.1002/pros.24267